-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Zhitong Finance App, Shengnuo Pharmaceutical-B (02257.HK) announced that on August 14, 2026, the Company and its direct wholly-owned subsidiary Shengnuo (Hong Kong) Limited (collectively, the “Plaintiff”) have filed a writ of subpoena (case number: HCA1427/2026) with the Hong Kong Special Administrative Region High Court (court) to sue several former management of the Group, including Dr. Lu Yang, Dr. Dai Xiaochang and Mr. Ye Yongji (collectively, the “Defendants”).

Zhitongcaijing·08/14/2026 13:09:11
Listen to the news
According to Zhitong Finance App, Shengnuo Pharmaceutical-B (02257.HK) announced that on August 14, 2026, the Company and its direct wholly-owned subsidiary Shengnuo (Hong Kong) Limited (collectively, the “Plaintiff”) have filed a writ of subpoena (case number: HCA1427/2026) with the Hong Kong Special Administrative Region High Court (court) to sue several former management of the Group, including Dr. Lu Yang, Dr. Dai Xiaochang and Mr. Ye Yongji (collectively, the “Defendants”).